Changes in estimated glomerular filtration rate in chronic myeloid leukemia patients treated front line with available TKIs and correlation with cardiovascular events

医学 尼罗替尼 达沙替尼 内科学 伊马替尼 肾功能 髓系白血病 酪氨酸激酶抑制剂 队列 肿瘤科 甲磺酸伊马替尼 肾脏疾病 心脏病学 癌症
作者
Matteo Molica,Emilia Scalzulli,Gioia Colafigli,Danilo Alunni Fegatelli,Fulvio Massaro,Roberto Latagliata,Robin Foà,Massimo Breccia
出处
期刊:Annals of Hematology [Springer Science+Business Media]
卷期号:97 (10): 1803-1808 被引量:22
标识
DOI:10.1007/s00277-018-3375-9
摘要

We investigated the median estimated glomerular filtration rate (eGFR) changes in chronic myeloid leukemia (CML) patients treated front line with tyrosine kinase inhibitors (TKIs). A large cohort of 397 patients-320 treated front line with imatinib, 25 with dasatinib, and 53 with nilotinib-was retrospectively analyzed at a single institution. The eGFR was calculated according to the Chronic Kidney Disease Epidemiology Collaboration equation for all patients at baseline and then at 6 and 12 months, and at the last follow-up. Taking into account eGFR changes during the first year of treatment and excluding other possible cardiovascular risk factors, we considered also the percentage of cardiovascular events in patients with modifications of this single parameter. Imatinib induced a decrease in median eGFR (p = 0.01): 42 patients treated with imatinib had a cardiovascular event, related to modification of eGFR, in the absence of other cardiovascular risk factors. In patients treated with nilotinib, the median eGFR did not decline from baseline: only 1 patient experienced an ischemic event, but the eGFR remained unchanged. In patients treated with dasatinib, the mean eGFR did not change significantly: 3 patients experienced a cardiac ischemic event, but in all patients the eGFR remained unchanged over time, while advanced age and metabolic alterations contributed to the ischemic events. This long-term follow-up has documented that imatinib may induce changes in the eGFR, which may contribute to the onset of ischemic events. Further analyses on larger series of CML patients are required to conclusively define the potential renal toxicity of second generation TKIs and the consequent risk of developing ischemic events.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
宇宙第一帅发布了新的文献求助200
刚刚
羊肉泡馍发布了新的文献求助10
刚刚
徐小赞发布了新的文献求助10
1秒前
结实大白完成签到,获得积分10
2秒前
PRIPRO关注了科研通微信公众号
2秒前
魔幻的觅珍完成签到,获得积分10
2秒前
文献达人完成签到,获得积分10
2秒前
2秒前
2秒前
共享精神应助欢喜的心情采纳,获得10
2秒前
冰千蕙发布了新的文献求助10
3秒前
MZ发布了新的文献求助10
4秒前
时尚战斗机应助善良的人采纳,获得10
4秒前
5秒前
领导范儿应助满anna采纳,获得10
5秒前
秦玉蓉发布了新的文献求助10
6秒前
7秒前
必中完成签到,获得积分20
8秒前
英姑应助wang采纳,获得10
9秒前
所所应助ylver采纳,获得50
9秒前
reirei应助sun_lin采纳,获得10
10秒前
眼睛大雨筠应助云ch采纳,获得60
11秒前
热心市民小红花应助Cici采纳,获得10
13秒前
秦玉蓉完成签到,获得积分10
13秒前
传奇3应助微微采纳,获得10
14秒前
14秒前
美丽灵活呜呜豹完成签到,获得积分10
16秒前
香蕉觅云应助CQ采纳,获得10
18秒前
18秒前
Salut完成签到,获得积分10
19秒前
量子星尘发布了新的文献求助10
19秒前
传奇3应助gu采纳,获得10
19秒前
20秒前
20秒前
默默安双完成签到 ,获得积分20
22秒前
ZXCVB发布了新的文献求助10
22秒前
pipi发布了新的文献求助10
23秒前
曹璐瑶发布了新的文献求助10
23秒前
25秒前
里德完成签到 ,获得积分10
25秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Toward a Combinatorial Approach for the Prediction of IgG Half-Life and Clearance 500
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3969940
求助须知:如何正确求助?哪些是违规求助? 3514642
关于积分的说明 11175298
捐赠科研通 3249947
什么是DOI,文献DOI怎么找? 1795178
邀请新用户注册赠送积分活动 875617
科研通“疑难数据库(出版商)”最低求助积分说明 804891